Beranda › Kanker Paru Sel Kecil › New York › New York City
Uji klinis Kanker Paru Sel Kecil di New York City, NY
22 studi untuk Kanker Paru Sel Kecil mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Menerima pesertaFase 1/2
- Avenzo Therapeutics Recruiting Site, New York
A Study of Armored CAR T Cells in People With Cancer
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Menerima pesertaFase 3
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Menerima pesertaFase 1/2
- Memorial Sloan Kettering, New York
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
- Icahn School of Medicine at Mount Sinai PRIME, New York
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Menerima pesertaFase 1
- NYU Langone Health, New York
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Menerima pesertaFase 1
- New York University Cancer Institute, New York
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Menerima pesertaFase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
- New York University Cancer Center - Laura and Isaac, New York
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Menerima pesertaFase 1/2
- Columbia University Medical Center - Herbert Irving Pavilion, New York
A Study of LY4175408 in Participants With Advanced Cancer
Menerima pesertaFase 1
- Columbia University, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Hospital-at-Home for People Receiving Tarlatamab
Menerima peserta
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Lung Cancer Biomarkers and Screening
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- NYU Cancer Institute at New York University Medical Center, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Menerima pesertaFase 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Research Site 107, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Menerima pesertaStudi observasional
- Icahn School of Medicine at Mount Sinai, New York
Uji klinis Kanker Paru Sel Kecil di kota lain
- Houston, TX26 studi
- Arlington, VA23 studi
- Boston, MA21 studi
- Los Angeles, CA20 studi
- Nashville, TN20 studi
- Orlando, FL15 studi
- Dallas, TX13 studi
- Cleveland, OH13 studi
- Chicago, IL13 studi
- St. Louis, MO13 studi
- Detroit, MI12 studi
- Washington, DC12 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.